IMPEL NEUROPHARMA INC
Net BuyingIMPL·US·🇺🇸 US
67%buys·33%sales
384 transactions$334.9MTotal buys·36 buys
$222KTotal sells·18 sells
6363 insiders
Last: Apr 5, 2024
| Date | Insider | Type | Value | |
|---|---|---|---|---|
| Apr 5, 24 | Allison David D. | Other | - | |
| Apr 5, 24 | Allison David D. | Other | - | |
| Apr 5, 24 | Allison David D. | Other | - | |
| Apr 5, 24 | NELSON TIMOTHY S | Other | - | |
| Apr 5, 24 | NELSON TIMOTHY S | Other | - | |
| Apr 5, 24 | NELSON TIMOTHY S | Other | - | |
| Apr 5, 24 | NELSON TIMOTHY S | Other | - | |
| Apr 5, 24 | NELSON TIMOTHY S | Other | - | |
| Apr 5, 24 | NELSON TIMOTHY S | Other | - | |
| Apr 5, 24 | Wilfong Diane E | Other | - |
IMPEL NEUROPHARMA INC (IMPL) has recorded 384 insider transactions from 63 insiders. Total insider buying volume stands at $334.9M, while total selling volume is $222K. Overall insider sentiment is bullish (67% purchases).
IMPEL NEUROPHARMA INC (IMPL) has recorded 384 insider operations, including 36 open-market purchases ($334.9M), 18 sales ($222K) and 330 other operations (stock option exercises, grants, tax dispositions, donations). The insider sentiment is bullish (67% purchases).
IMPEL NEUROPHARMA INC shows moderate insider activity with 6 active months out of the last 12, typical of a company whose trading windows are concentrated around financial disclosures.
Among the most active insiders are ADAMS ADRIAN (CEO), Kalb Michael Wayne (CFO) & Leaman John Harold (CFO), with respectively 119, 194, 16 transactions.
Across all 384 recorded transactions, the breakdown by type is: exercise (226, 59%), other (70, 18%), buys (36, 9%), grant (33, 9%), sales (18, 5%).
Data sourced from regulatory filings (SEC Form 4, AMF, BaFin, FI, and other European authorities).
IMPEL NEUROPHARMA INC has recorded 384 insider operations in total, including 36 open-market purchases ($334.9M), 18 sales ($222K) and 330 other operations (stock option exercises, grants, tax dispositions, donations). The most recent transaction was recorded on April 5, 2024.
Insiders at IMPEL NEUROPHARMA INC are currently net buyers, with 67% purchases and 33% sales across all reported transactions. Total buy volume is $334.9M versus $222K in sales, indicating a bullish insider sentiment.
InsiderLens tracks 63 insiders at IMPEL NEUROPHARMA INC (IMPL). ADAMS ADRIAN (CEO, 119 tx), Kalb Michael Wayne (CFO, 194 tx), Leaman John Harold (CFO, 16 tx). Data is sourced from mandatory regulatory filings for persons with access to privileged information.
The insider signal for IMPL is bullish, based on a 67% buy ratio across 54 buy and sell transactions reported to financial regulators. Transactions from C-suite executives (CEO, CFO) and board members are generally considered the most informative signals.
Insider trading data for IMPEL NEUROPHARMA INC comes from official regulatory filings: SEC Form 4 (United States), AMF (France), BaFin (Germany), FI (Sweden), and other European financial authorities. These filings are mandatory for directors, officers, and holders of more than 10% of a company's shares. InsiderLens aggregates and normalizes this data for analysis.